Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER ‐2 trial emulation with real‐world data

Documenti analoghi

• Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts
  di: Gian Paolo Fadini, et al.
  Pubblicazione: (2024)
• IDegLira for the real‐world treatment of type 2 diabetes in Italy. Final results from the REX observational study
  di: Gian Paolo Fadini, et al.
  Pubblicazione: (2024)
• Clinical efficacy and cost‐effectiveness of metformin in different patient populations: A narrative review of real‐world evidence
  di: Anna Solini, et al.
  Pubblicazione: (2024)
• PIONEER REAL Saudi Arabia: A multicentre, prospective, real‐world study of once‐daily oral semaglutide use in adults with type 2 diabetes in Saudi Arabia
  di: Hussein ElBadawi, et al.
  Pubblicazione: (2025)
• Effectiveness and safety of daily oral semaglutide in people with type 2 diabetes mellitus switching from sulfonylureas: A real‐world retrospective study
  di: Silvana Costa, et al.
  Pubblicazione: (2025)